Inorganic surface passivation of PbS nanocrystals resulting in strong photoluminescent emission

Strong photoluminescent emission has been obtained from 3 nm PbS nanocrystals in aqueous colloidal solution, following treatment with CdS precursors. The observed emission can extend across the entire visible spectrum and usually includes a peak near 1.95 eV. We show that much of the visible emission results from absorption by higher-lying excited states above 3.0 eV with subsequent relaxation to and emission from states lying above the observed band-edge of the PbS nanocrystals. The fluorescent lifetimes for this emission are in the nanosecond regime, characteristic of exciton recombination.

Separating fluorescent species of aqueous PbS semiconductor nanocrystals using micro-emulsions

Colloidal PbS nanocrystals over-coated with CdS are prepared in aqueous solutions and exhibit strong photoluminescence with two distinct peaks in the visible regime. A photoluminescence peak is observed at 640 nm, which is attributed to the band edge recombination in the PbS nanocrystals, and another peak at 510 nm, which is above the band edge of the PbS nanocrystals. The two PL peaks are isolated by extracting separate species of nanocrystal based upon their surface morphology. Micro-emulsions of hexane:PVA are used to remove the species containing the PL peak at 640 nm from the solution, leaving a singular peak at 510 nm. We show conclusively that the double-peaked structure observed in the photoluminescence spectra of PbS nanocrystals over-coated with CdS is due to the presence of two distinctly different nanocrystal species.

Estudio de la obtención de nanopartículas de PbS bajo distintas condiciones de síntesis.

Tesis (Maestro en Ciencias de la Ingeniería Mecánica con Especialidad en Materiales) UANL, 2013.

Productos Bioterapéuticos Similares (PBS). Panorama actual en América Latina en el contexto de la Artritis Reumatoide. Revisión sistemática de la literatura

Los productos bioterapéuticos han revolucionado la terapéutica de enfermedades como la artritis reumatoide (AR). Los altos costos y el vencimiento de las patentes de productos bioterapéuticos de referencia (innovadores) han promovido el interés en productos bioterapéuticos similares (PBS), también conocidos como biosimilares. METODOLOGÍA: revisión sistemática con el objetivo de presentar el panorama actual (a Octubre del 2012) de los PBS en Latinoamérica (LA) en el contexto de AR. Consulta de: bases de datos internacionales y latinoamericanas, sitios web gubernamentales, registros de ensayos clínicos, noticias y páginas web relevantes. Se siguieron las guías PRISMA. RESULTADOS: Bases de datos: Selección de 30 artículos según criterios de inclusión. Selección de 17 artículos según revisión detallada. Búsqueda manual: selección de 45 referencias. Consolidado de 62 documentos. Regulaciones vigentes sobre PBS: México, Cuba, Guatemala, Costa Rica, Panamá, Venezuela, Perú, Brasil, Chile y Argentina. En Colombia se encontró una propuesta en desarrollo. PBS aprobados: Colombia (Etanar®, PBS de Etanercept), México (Kikuzubam®, PBS de Rituximab), Perú, Chile y Bolivia (En estos últimos 3 países, Reditux®, PBS de Rituximab). DISCUSIÓN: La situación regulatoria sobre PBS en LA ha mejorado en los últimos 6 años, sin embargo las regulaciones deben buscar mayor claridad. Deben desarrollarse esfuerzos para establecer regulaciones en los países de LA que no las tienen. Países como México, Cuba y Brasil tienen una industria biotecnológica creciente. La aprobación de PBS en LA ha generado controversia y opiniones divididas entre los diferentes actores. El ingreso de PBS es beneficioso pero debe seguir regulaciones claras que garanticen eficacia y seguridad.

Magnetic and optical characterization of Mn-doped PbS nanocrystals supported in oxide glass matrix

The evidence of successful growth of Mn-doped PbS (Pb(1-x)Mn(x)S) nanocrystals (NCs) in SiO(2)-Na(2)CO(3)-Al(2)O(3)-PbO(2)-B(2)O(3) template, using the fusion method, is reported on in this study. The as-grown Pb(1-x)Mn(x)S NC is characterized using optical absorption, electron paramagnetic resonance, and atomic force microscopy. The data are discussed in terms of two distinct scenarios, namely a core-doped and a shell-doped nanostructure. (C) 2008 Elsevier B.V. All rights reserved.

Effect of PbS impurity on crystallization mechanism of phosphate glasses studied by differential scanning calorimetry

In this work, differential scanning calorimetry (DSC) was used to study effect of PbS impurity on crystallization mechanism of phosphate glasses. Bulk glasses presented one crystallization peak while powdered glasses presented two distinct crystallization peaks. For both undoped and doped glasses were determined the activation energies for the crystallization and the Avrami n parameters. The activation energies for undoped phosphate glass were 336 +/- 6 and 213 +/- 3 kJ mol(-1), respectively, associated with first and second crystallization peaks. For doped glass, the obtained energies were 373 +/- 9 and 286 +/- 7 kJ mol(-1). The calculated Avrami parameters, based on first crystallization peaks, for undoped and doped glasses were 2.25 +/- 0.01 and 1.75 +/- 0.02, respectively. These values suggest that the first DSC peak, in both glasses, may be associated with surface crystallization. (C) 2002 Elsevier B.V. B.V. All rights reserved.

Preparação e caracterização de semicondutores de PbS e 'B IND. I 'IND. 2' 'S IND. 3' obtidos pelo método de deposição em banho químico

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Nuovi elastomeri termoplastici "soft-hard" a base di pbs per applicazioni biomedicali

Nuovi elastomeri termoplastici "soft-hard" a base di PBS per applicazioni biomedicali

Constitution and Specific Gravity of the Ternary Mattes Cu2S-Sb2S3-PbS

The constitution of the ternary mattes Cu2S PbS Sb2S3 has never been completely investigated nor has there been any attempt to draw the complete ternary diagram. The following work is intended to [be] a contribution towards completion of this diagram by determining the specific gravity of different mattes and by pointing out some which show peculiarities of structure.

Constitution and Specific Gravity of the Ternary Mattes Cu2S-FeS-PbS.

The constitution of the ternary mattes CU2S-FeS-PbS has never been completely investigated. Fulton and Goodner 1) have investigated the binary mattes CU2S-FeS, CU2S-PbS, PbSFeS and have shown that the three binaries show eutectics. There has been no attempt however to draw the complete ternary diagram. The following work is intended to be a contribution toward the completion of this diagram by first of all pointing out those mattes which separate on melting into two layers, and second by determining the specific gravities of mattes of different compositions.

Mode-locked diode-pumped vanadate lasers operated with PbS quantum dots

The use of glasses doped with PbS nanocrystals as intracavity saturable absorbers for passive Q-switching and mode locking of c-cut Nd:Gd0.7Y0.3VO4, Nd:YVO4, and Nd:GdVO4 lasers is investigated. Q-switching yields pulses as short as 35 ns with an average output power of 435 mW at a repetition rate of 6–12 kHz at a pump power of 5–6 W. Mode locking through a combination of PbS nanocrystals and a Kerr lens results in 1.4 ps long pulses with an average output power of 255 mW at a repetition rate of 100 MHz.

Improving 4D plan quality for PBS-based liver tumour treatments by combining online image guided beam gating with rescanning.

Pencil beam scanned (PBS) proton therapy has many advantages over conventional radiotherapy, but its effectiveness for treating mobile tumours remains questionable. Gating dose delivery to the breathing pattern is a well-developed method in conventional radiotherapy for mitigating tumour-motion, but its clinical efficiency for PBS proton therapy is not yet well documented. In this study, the dosimetric benefits and the treatment efficiency of beam gating for PBS proton therapy has been comprehensively evaluated. A series of dedicated 4D dose calculations (4DDC) have been performed on 9 different 4DCT(MRI) liver data sets, which give realistic 4DCT extracting motion information from 4DMRI. The value of 4DCT(MRI) is its capability of providing not only patient geometries and deformable breathing characteristics, but also includes variations in the breathing patterns between breathing cycles. In order to monitor target motion and derive a gating signal, we simulate time-resolved beams' eye view (BEV) x-ray images as an online motion surrogate. 4DDCs have been performed using three amplitude-based gating window sizes (10/5/3 mm) with motion surrogates derived from either pre-implanted fiducial markers or the diaphragm. In addition, gating has also been simulated in combination with up to 19 times rescanning using either volumetric or layered approaches. The quality of the resulting 4DDC plans has been quantified in terms of the plan homogeneity index (HI), total treatment time and duty cycle. Results show that neither beam gating nor rescanning alone can fully retrieve the plan homogeneity of the static reference plan. Especially for variable breathing patterns, reductions of the effective duty cycle to as low as 10% have been observed with the smallest gating rescanning window (3 mm), implying that gating on its own for such cases would result in much longer treatment times. In addition, when rescanning is applied on its own, large differences between volumetric and layered rescanning have been observed as a function of increasing number of re-scans. However, once gating and rescanning is combined, HI to within 2% of the static plan could be achieved in the clinical target volume, with only moderately prolonged treatment times, irrespective of the rescanning strategy used. Moreover, these results are independent of the motion surrogate used. In conclusion, our results suggest image guided beam gating, combined with rescanning, is a feasible, effective and efficient motion mitigation approach for PBS-based liver tumour treatments.